Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2000 1
2005 1
2006 1
2007 1
2009 1
2010 1
2011 1
2013 1
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Developing a robust sensor for infrared imaging bolometers.
Wurden GA, Partesotti G, Reimold F, Mukai K, Peterson BJ, Federici F. Wurden GA, et al. Among authors: partesotti g. Rev Sci Instrum. 2024 Sep 1;95(9):093503. doi: 10.1063/5.0219535. Rev Sci Instrum. 2024. PMID: 39225572
The infrared imaging video bolometer at Wendelstein 7-X.
Partesotti G, Wurden GA, Reimold F, Peterson BJ, Federici F, Mukai K, Siever KA, von Miller J, Zhang D, Demby A; W7-X Team. Partesotti G, et al. Rev Sci Instrum. 2025 Jun 1;96(6):063503. doi: 10.1063/5.0261413. Rev Sci Instrum. 2025. PMID: 40476856
Immunoglobulin mutational status detected through single-round amplification of partial V(H) region represents a good prognostic marker for clinical outcome in chronic lymphocytic leukemia.
Marasca R, Maffei R, Morselli M, Zucchini P, Castelli I, Martinelli S, Fontana M, Ravanetti S, Curotti M, Leonardi G, Cagossi K, Partesotti G, Torelli G. Marasca R, et al. Among authors: partesotti g. J Mol Diagn. 2005 Nov;7(5):566-74. doi: 10.1016/S1525-1578(10)60589-2. J Mol Diagn. 2005. PMID: 16258154 Free PMC article.
Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
Ferrario A, Merli F, Luminari S, Stelitano C, Mannina D, Russo M, Mazza P, Marcheselli L, Goldaniga MC, Federico M, Baldini L; Gruppo Italiano per lo Studio dei Linfomi. Ferrario A, et al. Ann Hematol. 2011 Mar;90(3):323-30. doi: 10.1007/s00277-010-1067-1. Epub 2010 Sep 17. Ann Hematol. 2011. PMID: 20848104 Clinical Trial.
The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 study.
Federico M, Luminari S, Gobbi PG, Sacchi S, Di Renzo N, Lombardo M, Merli F, Baldini L, Stelitano C, Partesotti G, Polimeno G, Montanini A, Mammi C, Brugiatelli M. Federico M, et al. Among authors: partesotti g. Eur J Haematol. 2006 Mar;76(3):217-29. doi: 10.1111/j.1600-0609.2005.00609.x. Eur J Haematol. 2006. PMID: 16451396 Clinical Trial.
12 results